IFNG and central nervous system cancer: One week after engrafting glioma cells to the brain of mice, the LPS/IFN‐γ MVs were infused in the tumor region, and one week after, a significant reduction of tumor size was observed, compared to the infusion of IL‐4 MVs that resulted in the increased tumor size.